A novel splice variant of the nuclear coactivator p120 functions strongly for androgen receptor: Characteristic expression in prostate disease
A novel splice variant of the nuclear coactivator p120 functions strongly for androgen receptor: Characteristic expression in prostate disease
复制标题
DOI:
10.1507/endocrj.k07e-133
复制
发表时间:
2008-08-01
影响因子:
2
通讯作者:
Mori, Masatomo
中科院分区:
文献类型:
--
作者:
Hosoya, Takeshi;Monden, Tsuyoshi;Mori, Masatomo
We cloned a novel splicing variant for nuclear coactivator p120(alpha), designated as p120 beta and studied its function and expression in several human prostate diseases. Transfection assays demonstrated that p120 beta functions as a strong coactivator for androgen receptor (AR), but weakly for other nuclear receptors. GST-pull down assay showed that a glutamine-rich region of the p120 bound to the ligand-binding domain of AR. Interestingly. p120 beta mRNAs were expressed predominantly in the normal prostate, androgen-responsive prostate cancers and all androgen-sensitive prostate cancer cell line, LNCaP, but weakly in recurrent cancers and the androgen-insensitive prostate cancer cell lilies PC3 and DU145. Furthermore, knockdown of p120 alpha by siRNA abolished coactivator activity oil thyroid hormone receptors (TR) and PPAR gamma, but did not affect that of ARs in PC3 cells. In addition, competitive assay with other nuclear receptors demonstrated that TR and PPAR gamma did not inhibit p120 beta-induced stimulation. These findings Suggested that while p120 alpha was essential for ligand-dependent stimulation of TRs and PPAR gamma, p120 beta acted as a coactivating protein predominantly for AR.